Intracellular J chains in lymphoproliferative diseases.

Area of Science:

• Immunology
• Pathology
• Oncology

Background:

• J chain (joining chain) is a crucial component in the polymerization of immunoglobulins (Ig).
• Its presence and role in various lymphoproliferative diseases, including multiple myeloma and lymphomas, require further investigation.

Purpose of the Study:

• To investigate the presence and significance of J chain in different types of lymphoproliferative diseases.
• To determine the correlation between J chain positivity and clinical outcomes, such as survival and kidney lesions in multiple myeloma.
• To explore the association of J chain with immunoglobulin synthesis and B-cell malignancy.

Main Methods:

• Analysis of J chain presence in formol-paraffin tissue sections from patients with multiple myeloma and malignant lymphomas.
• Quantification of J chain positivity percentages in different disease subtypes.
• Assessment of kappa to lambda light chain ratios and correlation with J chain status and clinical data.

Main Results:

• J chain positivity varied across disease types: 58.9% in multiple myeloma, 70.7% in immunocytic lymphoma, and 37.1% in immunoblastic lymphoma.
• A subset of 8 cases exhibited 'J chain disease' with only J chains in tumor cells.
• J chain-positive multiple myeloma cases showed significantly longer survival (26.8 months) than J chain-negative cases (17.7 months).

Conclusions:

• J chain appears to be associated with early events in immunoglobulin synthesis in lymphoproliferative diseases.
• J chain status is a significant prognostic factor in multiple myeloma, impacting patient survival.
• The study highlights the potential role of J chain in the pathogenesis and clinical behavior of B-cell malignancies.